The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene
NCT02663830 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2017-08-16
Summary
The aim of the study is to evaluate the effect of sildenafil citrate on the pregnancy rate in women undergoing induction of ovulation using clomiphene citrate.
Conditions
- Anovulatory
Interventions
- DRUG
-
Sildenafil & clomiphene citrate
105 Patients will receive 25 mg sildenafil citrate 6hourly orally (day 6 to the end of the cycle), and clomiphene citrate 100 mg/day (day 2 to 6) orally by the patient, for induction of ovulation
- DRUG
-
clomiphene only
105 Patients will receive clomiphene citrate 100 mg/day (day 2 to 6) orally by the patient, for induction of ovulation
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-10
- Primary Completion
- 2017-01-10
- Completion
- 2017-03-12
More Related Trials
-
Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility
NCT05753098 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages
NCT01419392 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women
NCT03301233 ·Status: COMPLETED ·Phase: NA
-
Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses
NCT02362399 ·Status: COMPLETED ·Phase: NA
-
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
NCT04283435 ·Status: UNKNOWN ·Phase: PHASE1
-
Sildenafil and Outcome of IVF/ICSI Cycles
NCT03192709 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Use of Sildenafil Citrate in Management of Mild Pre-eclampsia
NCT03262961 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles
NCT03854175 ·Status: UNKNOWN ·Phase: NA
-
A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction
NCT02590536 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.
NCT01254396 ·Status: COMPLETED ·Phase: PHASE1
-
Sildenafil Citrate Therapy for Oligohydramnios
NCT02372487 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.
NCT01254383 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms
NCT02345980 ·Status: COMPLETED ·Phase: PHASE4
-
Sildenafil Citrate for Treatment of Growth-restricted Fetuses
NCT03177824 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.
NCT00795938 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Sildenafil in COVID-19
NCT04304313 ·Status: UNKNOWN ·Phase: PHASE3
-
A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers
NCT04100759 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects
NCT00866463 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacdynamics of Sildenafil
NCT00718185 ·Status: TERMINATED
-
Sildenafil Citrate and Intrapartum Fetal Distress
NCT04325243 ·Status: COMPLETED ·Phase: PHASE4
-
A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women
NCT02364882 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes
NCT05971667 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sildenafil and Uteroplacental Perfusion
NCT01107782 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
NCT04948151 ·Status: UNKNOWN ·Phase: PHASE2
-
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
NCT05765487 ·Status: COMPLETED ·Phase: PHASE1